Stratec Biomedical AG Stock Xetra
Equities
DE0007289001
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- EUR | - |
04-29 | STRATEC BIOMEDICAL SYSTEMS AG : Deutsche Bank reiterates its Neutral rating | ZD |
04-26 | STRATEC BIOMEDICAL SYSTEMS AG : Berenberg reiterates its Neutral rating | ZD |
Sales 2024 * | 266M 287M 392M | Sales 2025 * | 290M 313M 428M | Capitalization | 520M 562M 768M |
---|---|---|---|---|---|
Net income 2024 * | 16M 17.3M 23.61M | Net income 2025 * | 23M 24.87M 33.94M | EV / Sales 2024 * | 2.39 x |
Net Debt 2024 * | 116M 126M 171M | Net Debt 2025 * | 79.62M 86.09M 117M | EV / Sales 2025 * | 2.07 x |
P/E ratio 2024 * |
31.9
x | P/E ratio 2025 * |
22.4
x | Employees | - |
Yield 2024 * |
2.03% | Yield 2025 * |
2.12% | Free-Float | 59.43% |
Latest transcript on Stratec Biomedical AG
Managers | Title | Age | Since |
---|---|---|---|
Marcus Wolfinger
CEO | Chief Executive Officer | 56 | 98-02-28 |
Robert Siegle
DFI | Director of Finance/CFO | 57 | 98-04-30 |
Jan Keppeler
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Frank Hiller
BRD | Director/Board Member | 58 | 19-05-28 |
Georg Heni
CHM | Chairman | 66 | 22-05-19 |
Rolf Vornhagen
BRD | Director/Board Member | 71 | 20-07-20 |
1st Jan change | Capi. | |
---|---|---|
+12.20% | 225B | |
+10.80% | 186B | |
+13.15% | 135B | |
+25.66% | 107B | |
+0.84% | 63.56B | |
+5.62% | 51.32B | |
+12.67% | 51.04B | |
+8.70% | 43.3B | |
+4.79% | 36.99B |